Runcharoon Klao, Favro Margaret E, Logue Catherine M
Department of Population Health, College of Veterinary Medicine, University of Georgia, 501 D.W. Brooks Drive, Athens, GA 30602, USA.
J Appl Microbiol. 2025 Jan 6;136(1). doi: 10.1093/jambio/lxaf015.
To characterize Escherichia coli O25 ST131 (O25-ST131) isolated from Georgia poultry-a "global high-risk" clonal strain.
Using multiplex PCR to detect target genes in 98 isolates of avian pathogenic E. coli (APEC) O25 recovered from avians diagnosed with colibacillosis (n = 87) and healthy chicks (n = 11) in Georgia, USA. Eighty-eight isolates were classified as sequence type ST131 clade b and 56% (n = 49) belong to the phylogenetic group B2. Overall, 17% were identified as uropathogenic E. coli (UPEC)-like and 94% of the isolates formed strong to moderate biofilms. The extended-spectrum β-lactamases encoding genes, blaCTX M-15 (24%), carbapenemases encoding genes, and blaOXA48 (16%) were also detected. The isolates harbored FIB (88%), FIC (28%), A/C (14%), and FIIA (6%) plasmid replicons. Interestingly, 78% of the isolates were found to be resistant to chicken serum and 92% showed capabilities for growth in human urine. The isolates showed phenotypic resistance to several antibiotics including chloramphenicol (63%), ciprofloxacin (57%), trimethoprim-sulfamethoxazole (28%), streptomycin (17%), and cefoxitin and meropenem (14%) using the national antimicrobial resistance monitoring system panel.
Overall, our study provides evidence of the virulence of these global "high-risk" clones in Georgia poultry with some isolates showing genotypic overlap between APEC and UPEC. Also, this clone harbored several virulence genes, antimicrobial-resistant genes, and plasmids. Interestingly, the majority of APEC O25-ST131 isolates can survive and grow in both chicken serum and human urine and warrant further investigation of their potential pathogenicity for both chickens and humans.
对从格鲁吉亚家禽中分离出的大肠杆菌O25 ST131(O25 - ST131)——一种“全球高风险”克隆菌株进行特性分析。
采用多重聚合酶链反应(multiplex PCR)检测从美国格鲁吉亚被诊断患有大肠杆菌病的禽类(n = 87)和健康雏鸡(n = 11)中分离出的98株禽致病性大肠杆菌(APEC)O25中的目标基因。88株分离株被归类为序列型ST131进化枝b,56%(n = 49)属于系统发育群B2。总体而言,17%被鉴定为类似尿路致病性大肠杆菌(UPEC),94%的分离株形成强至中度生物膜。还检测到超广谱β - 内酰胺酶编码基因blaCTX M - 15(24%)、碳青霉烯酶编码基因和blaOXA48(16%)。分离株携带FIB(88%)、FIC(28%)、A/C(14%)和FIIA(6%)质粒复制子。有趣的是,发现78%的分离株对鸡血清有抗性,92%显示出在人尿中生长的能力。使用国家抗菌药物耐药性监测系统面板,分离株对几种抗生素表现出表型抗性,包括氯霉素(63%)、环丙沙星(57%)、甲氧苄啶 - 磺胺甲恶唑(28%)、链霉素(17%)以及头孢西丁和美罗培南(14%)。
总体而言,我们的研究提供了这些全球“高风险”克隆株在格鲁吉亚家禽中毒力的证据,一些分离株显示出APEC和UPEC之间的基因型重叠。此外,该克隆株携带多种毒力基因、抗菌耐药基因和质粒。有趣的是,大多数APEC O25 - ST131分离株能够在鸡血清和人尿中存活和生长,因此有必要进一步研究它们对鸡和人的潜在致病性。